This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nearly 900 people in 23 countries have been infected with the H5N1 bird flu virus since it started spreading from Southeast Asia in late 2003. But previous human cases were all linked to transmission from infected birds, typically domestic poultry. Read the rest…
A new Netflix TV show about the origins and consequences of the opioid epidemic is coming to the small screen. The show, “Painkiller,” is a fictional story based on real events that transpired around the Sackler family, Purdue Pharma, and the marketing and distribution of their drug, OxyContin.
The nation’s longstanding racial and ethnic health inequities will not improve unless Congress steps in to provide affordable health insurance for all and federal agencies start enforcing existing laws against discrimination and improve collection of racial and ethnic data, said the authors of a new report released Wednesday.
The nonprofit research institute, based in Seattle, was founded in 2003 by Microsoft co-founder and philanthropist Paul Allen to go after big and basic scientific questions. Mapping the billions of cells that make up the brain is a task mammoth enough to keep hundreds of researchers across continents busy for years.
Holmes was sentenced in November 2022 to 11 years in prison following a trial that determined she knew her blood-testing startup, which was founded in 2003 and which claimed to be able to test for a range of diseases and risks with one finger prick, produced inaccurate and faulty results. military to use its tests on the battlefield.
The price of Humira rose 470% in the 20 years following its launch in 2003 to reach upward of $84,000 annually. Cyltezo is one of the only biosimilars that can be substituted for Humira at the pharmacy counter without a doctor’s permission, so it is in a better competitive position than most others.
When Francis Collins, then-director of the National Human Genome Research Institute, testified before Congress in 2003 about the significance of sequencing the human genome that year, he introduced personalized medicine as a new concept.
In 2003, during Europe’s worst heat wave in centuries, almost 15,000 people died in France. About three-quarters of those deaths occurred indoors , and approximately 80% of the people who died were over 75 , an age at which people tend to be less capable of perceiving heat and less well-equipped to adapt to it.
” The answer invariably comes back to a popular 2003 journal article from a quartet of health economists titled, “ It’s The Prices, Stupid.” ” Continue to STAT+ to read the full story…
Five studies co-authored by Tessier-Lavigne are now under the microscope for containing alleged altered images: a 1999 Cell study , a 2008 paper in the EMBO Journal, a 2003 Nature study, and two studies published in 2001 in Science.
Danyel Smith has served 21 years of a life sentence at Dooly Correctional Facility in Unadilla, Georgia, for the 2003 murder of his two-month-old son, Chandler.
The human genome was sequenced in 2003. The act also created an industry that didn’t exist in the United States before its enactment, enabling the formation of companies to develop and commercialize therapies for rare diseases. That said, a lot has changed in science and drug development since 1983.
In 2003, the year Nora Volkow was appointed director of the National Institute on Drug Abuse, roughly 4,000 Americans died of opioid overdose. In the two decades since, the overdose crisis has morphed into a full-fledged public health emergency, with 80,000 Americans dying from opioid overdoses each year. treats opioid addiction.
billion in 2003 to $42.9 But that could end up hammering the NIH budget, which has steadily climbed over the years as Congress channeled billions of dollars to research on cancer, Alzheimer’s disease, and rare diseases. The NIH’s overall budget nearly doubled from $25.8 billion in 2022.
biomedical research powerhouse, a role he held from 2003 to 2021, when he was appointed to serve as the White House’s first Cabinet-level science adviser to the president. But the founding director will not be back at the helm of the Cambridge, Mass.,
The precedent established in 2003, when the court ruled that race, along with other factors, could be given limited consideration in higher education admissions when necessary to achieve student body diversity, is now in jeopardy.
In 2003, Pancho’s life changed forever. That’s when a car crash sent the 20-year-old farm worker into emergency surgery to repair damage to his stomach. The operation went well, but the next day, a blood clot caused by the procedure cut off oxygen to his brain stem, leaving him paralyzed and unable to speak.
Both are run by a husband-and-wife team that has received more than $17 million in NIH funding since 2003, according to the animal rights group. ” The move came more than six months after the People for the Ethical Treatment of Animals notified both the U.S.
Advisors, a hedge-fund firm run by brothers Felix and Julian Baker, had in 2003 invested in Seagen, a developer of next-generation cancer treatments. Pfizer bought Baker Bros. Pfizer bought the company for $43 billion last year.
Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions. Yale and professor John Krystal agreed to pay $1.5 million to resolve claims that they failed to pay the VA its share of royalties for patents covering intranasal ketamine used to treat depression.
The group now has 419 approvals and has so far filed 483* ANDAs since the commencement of the filing process in FY 2003-04. (*As Eluxadoline tablets had annual sales of USD 243.7 mn in the United States (IQVIA MAT January 2025). As of December 31, 2024.)
It was initially approved by the FDA in 2003 for use in individuals 5 through 49 years of age, and in 2007, the FDA approved the use of FluMist to include children 2 through 5 years of age. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age.
With this approval, Zydus Lifesciences now has 419 approvals and has filed a total of 483* Abbreviated New Drug Applications (ANDAs) since the filing process began in the financial year 2003-04. (*As As on 31 st December, 2024.)
Furthermore, this period also coincided with the advent of the biotech industry, whereby the 2003 completion of the human genome project catalysed gene therapy developments. The period between 2012 and 2020 saw another rapid increase in the annual numbers of review designations awarded.
The US Food and Drug Administration (FDA) has approved Biogenâs Aduhelm (aducanumab) for the treatment of Alzheimerâs: making it the first new treatment approved for the disease since 2003.
In 2003 the Human Genome Project provided the first atlas. Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation.
The group now has 399 approvals and has so far filed over 460 ANDAs (as of March 2024) since the commencement of the filing process in FY 2003-04. Sacubitril and Valsartan tablets had annual sales of USD 5,483 mn in the United States (IQVIA MAT May 2024).
If the agency approves it, aducanumab would be the first new Alzheimer’s treatment since 2003. Patients are desperate for new options, but some scientists say there isn’t enough evidence it works.
The group now has 393 approvals and has so far filed over 460* ANDAs since the commencement of the filing process in FY 2003-04. Mirabegron Extended-Release Tablets USP 25mg and 50mg had annual sales of $2.42 billion in the US (IQVIA MAT February 2024). The post Zydus launches Mirabegron ER tablets in US appeared first on Express Pharma.
The group now has 363 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in FY 2003-04. Roflumilast Tablets, 250 mcg had annual sales of $34 million in the United States (IQVIA MAT Feb. The post Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg appeared first on Express Pharma.
The group now has 387 approvals and has so far filed over 460* ANDAs since the commencement of the filing process in FY 2003-04. Dexamethasone Tablets USP, 1 mg had annual sales of $1.8 million in the United States (IQVIA Dec. The post Zydus gets tentative USFDA approval for Dexamethasone Tablets USP, 1 mg appeared first on Express Pharma.
Lancet 2003; 361 (9373): 1935-8. PMID 29855084 De Silva HA, Fonseka MM, Pathmeswaran A et al. Multiple dose activated charcoal for treatment of yellow oleander poisoning: A single-blind, randomized placebo controlled trial.
The group now has 381 approvals and has so far filed over 444* ANDAs since the commencement of the filing process in FY 2003-04. Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL), SingleDose Vial had annual sales of $986 million in the United States (IQVIA MAT Aug 2023).
The group now has 395 approvals and has so far filed over 460 (as of 31st December, 2023) ANDAs since the commencement of the filing process in FY 2003-04. Dexamethasone Tablets USP, 1 mg had annual sales of $ 1.8 million in the United States (IQVIA MAT March 24).
Two decades after the Medicare Modernization Act of 2003 created Medicare Part D, nearly 50 million Americans are enrolled in a standalone prescription drug benefit program.
In 2003, Tommy was diagnosed with Duchenne Muscular Dystrophy (DMD) , a genetic disorder where the body does not maintain muscle mass due to an inborn lack of the protein dystrophin. On Rare Disease Day, we are dedicating this blog to Tommy, a selfless and caring individual we had the opportunity to serve for several years.
The group now has 386 approvals and has so far filed over 448* ANDAs since the commencement of the filing process in FY 2003-04. Dexamethasone Tablets USP, 0.5 mg, 4 mg and 6 mg had annual sales of $22 million and Dexamethasone Tablets USP, 2 mg has annual sales of $6 million in the United States (IQVIA Dec.
The group now has 382 approvals and has so far filed over 448* ANDAs since the commencement of the filing process in FY 2003-04. Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of $136.5 million in the United States (IQVIA MAT October,2023). The post Zydus gets US FDA final approval for Ivabradine Tablets, 5 mg and 7.5
Now many believe the money might have been better spent on public health interventions After spending 13 years and $2.7bn, the Human Genome Project announced in 2003 that it had successfully mapped our DNA, paving the way for a new era of medicine that would deliver “the right treatment, for the right patient, at the right time”.
Between 1935 and 2003, the world saw the introduction of 14 new classes of antibiotics. The growing threat of antimicrobial resistance AMR is a pressing issue, with the pace of bacterial resistance outstripping the development of new antibiotics. However, over the last 20 years, new approvals have dwindled significantly.
The group now has 358 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in FY 2003-04. Acetazolamide Tablets USP, 125 mg and 250 mg had annual sales of USD 16 mn in the United States (IQVIA MAT Dec.
The group now has 378 approvals and has so far filed over 444 ANDAs since the commencement of the filing process in FY 2003-04. Isotretinoin Capsules USP, 10 mg, 20 mg 30 mg and 40 mg had annual sales of $165 million in the United States (IQVIA MAT July 2023).
The group now has 359 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in FY 2003-04. Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg had annual sales of $75 million in the United States (IQVIA MAT Dec.
96
96
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content